PURPOSE: To analyze BRCA1 and BRCA2 genes using a cost-effective and rapid approach based on next generation sequencing (NGS) technology. METHODS: A population of Spanish cancer patients with a personal or familial history of breast and/or ovarian cancer was analyzed for germline mutations in BRCA1 and BRCA2 genes. The methodology relies on a 5 multiplex PCR assay coupled to NGS. RESULTS: Ten pathogenic mutations (four in BRCA1 and six in BRCA2 gene) were identified in a Spanish population. The deletion c.1792delA, in exon 10, and the duplication c.5869dupA, in exon 11 of BRCA2 gene were not previously reported and should be considered as pathogenic due to its frameshift nature. CONCLUSION: Two novel frameshift mutations in BRCA2 gene were detected using the multiplex PCR-based assay following by NGS.
PURPOSE: To analyze BRCA1 and BRCA2 genes using a cost-effective and rapid approach based on next generation sequencing (NGS) technology. METHODS: A population of Spanish cancerpatients with a personal or familial history of breast and/or ovarian cancer was analyzed for germline mutations in BRCA1 and BRCA2 genes. The methodology relies on a 5 multiplex PCR assay coupled to NGS. RESULTS: Ten pathogenic mutations (four in BRCA1 and six in BRCA2 gene) were identified in a Spanish population. The deletion c.1792delA, in exon 10, and the duplication c.5869dupA, in exon 11 of BRCA2 gene were not previously reported and should be considered as pathogenic due to its frameshift nature. CONCLUSION: Two novel frameshift mutations in BRCA2 gene were detected using the multiplex PCR-based assay following by NGS.
Authors: Imma Hernan; Emma Borràs; Miguel de Sousa Dias; María José Gamundi; Begoña Mañé; Gemma Llort; José A G Agúndez; Miguel Blanca; Miguel Carballo Journal: J Mol Diagn Date: 2012-03-16 Impact factor: 5.568
Authors: Lídia Feliubadaló; Adriana Lopez-Doriga; Ester Castellsagué; Jesús del Valle; Mireia Menéndez; Eva Tornero; Eva Montes; Raquel Cuesta; Carolina Gómez; Olga Campos; Marta Pineda; Sara González; Victor Moreno; Joan Brunet; Ignacio Blanco; Eduard Serra; Gabriel Capellá; Conxi Lázaro Journal: Eur J Hum Genet Date: 2012-12-19 Impact factor: 4.246
Authors: J Peto; N Collins; R Barfoot; S Seal; W Warren; N Rahman; D F Easton; C Evans; J Deacon; M R Stratton Journal: J Natl Cancer Inst Date: 1999-06-02 Impact factor: 13.506
Authors: Maurice Chan; Shen Mo Ji; Zhen Xuan Yeo; Linda Gan; Eric Yap; Yoon Sim Yap; Raymond Ng; Puay Hoon Tan; Gay Hui Ho; Peter Ang; Ann Siew Gek Lee Journal: J Mol Diagn Date: 2012-08-22 Impact factor: 5.568
Authors: Orland Díez; Ana Osorio; Mercedes Durán; José Ignacio Martinez-Ferrandis; Miguel de la Hoya; Raquel Salazar; Ana Vega; Berta Campos; Raquel Rodríguez-López; Eladio Velasco; Javier Chaves; Eduardo Díaz-Rubio; Juan Jesús Cruz; María Torres; Eva Esteban; Andrés Cervantes; Carmen Alonso; Juan Manuel San Román; Rogelio González-Sarmiento; Cristina Miner; Angel Carracedo; María Eugenia Armengod; Trinidad Caldés; Javier Benítez; Montserrat Baiget Journal: Hum Mutat Date: 2003-10 Impact factor: 4.878
Authors: Kim De Leeneer; Joachim De Schrijver; Lieven Clement; Machteld Baetens; Steve Lefever; Sarah De Keulenaer; Wim Van Criekinge; Dieter Deforce; Filip Van Nieuwerburgh; Sofie Bekaert; Filip Pattyn; Bram De Wilde; Paul Coucke; Jo Vandesompele; Kathleen Claes; Jan Hellemans Journal: PLoS One Date: 2011-09-30 Impact factor: 3.240
Authors: María Molina-Zayas; Carmen Garrido-Navas; Jose Luis García-Puche; Julian Barwell; Susana Pedrinaci; Margarita Martínez Atienza; Susana García-Linares; Tomás de Haro-Muñoz; Jose Antonio Lorente; M Jose Serrano; Antonio Poyatos-Andújar Journal: Mol Genet Genomics Date: 2022-04-22 Impact factor: 2.980